Ratings by CL King (Kristen Stewart)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/4/2024 | Teleflex | TFX | Maintain | Buy (N/A) |
|
Details | ||
| 10/25/2024 | Integer Holding | ITGR | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2024 | Boston Scientific | BSX | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2024 | Masimo Corp. | MASI | New Coverage | Neutral (N/A) |
143.49 (179.95) |
25.41% | Details | |
| 9/13/2024 | Haemonetics | HAE | New Coverage | Buy (N/A) |
73.26 (75.07) |
2.47% | Details | |
| 6/28/2024 | Penumbra | PEN | New Coverage | Buy (N/A) |
174.90 (318.57) |
82.14% | Details | |
| 4/11/2024 | Merit Medical Systems, Inc. | MMSI | New Coverage | Buy (N/A) |
71.95 (71.09) |
-1.2% | Details | |
| 4/8/2024 | Shockwave Medical | SWAV | Downgrade | Neutral (Buy) |
326.34 (334.75) |
2.58% | Details | |
| 3/14/2024 | Integer Holding | ITGR | New Coverage | Buy (N/A) |
113.90 (95.14) |
-16.47% | Details | |
| 1/12/2024 | Axonics Modulation Technologies Inc. | AXNX | Downgrade | Neutral (Buy) |
68.72 (70.98) |
3.29% | Details | |
| 12/14/2023 | ICU Medical | ICUI | New Coverage | Buy (N/A) |
92.11 (154.97) |
68.24% | Details | |
| 11/14/2023 | Integra LifeSciences | IART | New Coverage | Buy (N/A) |
36.60 (18.05) |
-50.68% | Details | |
| 10/11/2023 | Silk Road Medical | SILK | Downgrade | Neutral (Buy) |
13.99 (27.49) |
96.5% | Details | |
| 5/30/2023 | Teleflex | TFX | New Coverage | Buy (N/A) |
232.35 (133.99) |
-42.33% | Details | |
| 5/23/2023 | Silk Road Medical | SILK | New Coverage | Buy (N/A) |
31.46 (27.49) |
-12.62% | Details | |
| 5/23/2023 | Axonics Modulation Technologies Inc. | AXNX | New Coverage | Buy (N/A) |
51.61 (70.98) |
37.53% | Details | |
| 5/22/2023 | Avanos Medical | AVNS | New Coverage | Buy (N/A) |
22.53 (24.93) |
10.65% | Details | |
| 5/22/2023 | CONMED | CNMD | New Coverage | Buy (N/A) |
118.96 (33.83) |
-71.56% | Details |
